Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids

Daniela Stöhr1, Jens O Schmid2,3, Tobias B Beigl1

  • 1Institute of Cell Biology and Immunology, University of Stuttgart, 70569, Stuttgart, Germany.

Insights

Cancer cell spheroids show varied responses to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). TRAIL-resistant cells protect sensitive cells, increasing treatment resistance, but this can be overcome.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Biophysics

Background:

  • The 3D microenvironment's role in cancer cell apoptosis is not fully understood.
  • Cancer cell spheroids mimic micrometastases, offering a model to study treatment resistance.

Purpose of the Study:

  • To investigate how 3D microenvironments influence cancer cell susceptibility to TRAIL.
  • To understand the spatial distribution and mechanisms of TRAIL resistance in spheroids.

Main Methods:

  • Culturing cancer cell spheroids to mimic micrometastastases.
  • Analyzing spatial variations in cell populations and protein expression (TRAILR1, TRAILR2).
  • Investigating the effect of oxygen/nutrient levels and celecoxib on TRAIL sensitivity.

Main Results:

  • TRAIL-resistant subpopulations within spheroids protect TRAIL-hypersensitive cells, increasing overall resistance.
  • TRAIL resistance is linked to cell proliferation status and low TRAIL receptor expression.
  • Inner spheroid layers show high TRAILR2 expression due to hypoxia and nutrient deprivation.
  • Celecoxib enhances TRAILR2 expression and re-sensitizes resistant cells.

Conclusions:

  • Spatially organized heterogeneities in TRAIL response are key to spheroid treatment resistance.
  • Understanding these spatial barriers is crucial for developing effective cancer therapies.
  • Targeting receptor expression and microenvironmental factors can overcome TRAIL resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K